Drug research is dependent on novel approaches, now more than ever. The number of newly approved medicines with a clear health benefit for patients is too low. This is also an expression of the inadequate availability of potential new starting points. Surprising innovations are found primarily in the under explored areas of the chemical universe. Nature delivers precisely this: starting points which often surprise through their structural novelty and a new mode of action.
AnalytiCon’s synthetic libraries exploit the advantages of a natural product – for example, from biologically relevant partial structures of natural products we develop libraries which can be further optimized by medicinal chemistry. Surprises are where you least expect them.
In the last few years, fragment-based approaches have been established as efficient techniques that speed things up in the development of active substances. AnalytiCon’s “Fragments from Nature” approach represents a possibility to integrate natural product elements into this approach. Through our “growing by catalogue” concept, we make fragments available which, in the case of an affinity worth pursuing, permits an uncomplicated development based on already established chemistry.